Gongwin Biopharm Holdings Co., Ltd.(TW:6617)
NT$126.50+8.00 (+6.75%)
TW:6617
Gongwin Biopharm Holdings Co., Ltd. Revenue
NT$126.50
At close:+8.00 (+6.75%)
Gongwin Biopharm Holdings Co., Ltd. (6617) Revenue
Gongwin Biopharm Holdings Co., Ltd. Revenue
Gongwin Biopharm Holdings Co., Ltd. had a revenue of 12.69M in the quarter ending Jun 30, 2026, with 33.99%. This bring the company's revenue in the last twelve months to 42.22M, Increased 10.29%. In the fiscal year ending Dec 31, 2025, Gongwin Biopharm Holdings Co., Ltd. had annual revenue of 36.45M with 13.75% growth.
- Revenue (ttm)
- 42.22M
- Revenue Growth
- 11.66%
- P/S Ratio
- 414.57
- Revenue/Employee
- TWD 1,822,300
- Employees
- 20
- Market Cap
- TWD 15.11B
Revenue Chart
Gongwin Biopharm Holdings Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 36.45M | 4.41M | 13.75% |
| Dec 31, 2024 | 32.04M | 13.13M | 69.39% |
| Mar 31, 2024 | 18.91M | 17.77M | 1554.86% |
| Mar 31, 2023 | 1.14M | 0.00 | 0.00% |
| Dec 31, 2021 | 1.14M | 310.00K | 37.21% |
| Dec 31, 2020 | 833.00K | 585.00K | 235.89% |
| Dec 31, 2019 | 248.00K | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.